Cancer News and Research

Latest Cancer News and Research

Research: Children with inherited anti-inflammatory defect may have predisposition to lymphoma

New research shows that children with an inherited genetic defect in a critical anti-inflammatory pathway have a genetic predisposition to lymphoma. Results of the study, published online today in Blood, the Journal of the American Society of Hematology (ASH), reveal an important association between the genetic defect, which causes chronic intestinal inflammation and early onset inflammatory bowel disease, and its role in cancer development in infants and children.

3 Oct 2013

Depressed people may have triple times risk of developing Parkinson's

People who are depressed may have triple the risk of developing Parkinson's disease, according to a study published in the October 2, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology.

3 Oct 2013

NCI explores how erectile dysfunction drugs work to prevent colon cancer

Erectile dysfunction drugs may be able to help prevent or even treat colon cancer, researchers say.

3 Oct 2013

UCLA study shows how cocaine makes immune cells susceptible to HIV

In many ways, the spread of HIV has been fueled by substance abuse. Shared needles and drug users' high-risk sexual behaviors are just some of the ways that narcotics such as cocaine have played a key role in the AIDS epidemic in much of the world.

3 Oct 2013

New agreement to expand scope of research project to evaluate MCT-485 for primary liver cancer

MultiCell Technologies, Inc. is pleased to announce the signing of a new sponsored research agreement with Anand Ghanekar, M.D., Ph.D, of the University Health Network's Toronto General Hospital expanding the scope of the research project to evaluate MCT-485 in animal models for the treatment of primary liver cancer.

2 Oct 2013

Saint Luke's liver transplantation program receives CMS certification

The liver transplantation program at Saint Luke's Hospital of Kansas City has received certification by the Centers for Medicare and Medicaid. The certification is an important step in enhancing the hospital's ability to care for Medicare-covered patients suffering from end-stage liver disease, and attract other insurers who base their coverage on the CMS certification.

2 Oct 2013

Data analyses from Brisdelle Phase 3 pivotal trials to be showcased at NAMS' meeting

Noven Pharmaceuticals, Inc., today announced that 11 presentations, featuring data analyses from its Phase 3 pivotal trials that supported the recent U.S. Food and Drug Administration approval of Brisdelle (paroxetine capsules, 7.5 mg/day) for the treatment of moderate to severe vasomotor symptoms associated with menopause, will be showcased at the 2013 Annual Meeting of The North American Menopause Society in Dallas on Oct. 9-10.

2 Oct 2013

Epigenetic Markers Found For Head And Neck Cancers

...

2 Oct 2013

Hypertension Drug May Aid Cancer Treatment

...

2 Oct 2013

Sun Pharma, Intrexon Team Up To Target Ocular Diseases

...

2 Oct 2013

Esteya system for high precision skin cancer treatment gets FDA clearance

Esteya, an electronic brachytherapy system, has received 510(k) clearance from the U.S. Food and Drug Administration, enabling medical centers in the United States to offer their patients with skin cancer a new treatment option.

From Elekta 2 Oct 2013

Laboratory testing kit that estimates risk of breast cancer relapse gets FDA approval

A laboratory testing kit that estimates the risk of breast cancer relapse in spite of anti-hormone treatment has received approval from the U.S. Food and Drug Administration.

2 Oct 2013

Sheffield Hallam University encourage careers in radiotherapy with a series of open events

Lecturers at Sheffield Hallam University are trying to encourage more young people to consider a career in radiotherapy with a series of open events at hospitals aimed at tackling the increasing demand for patients receiving the treatment.

From Sheffield Hallam University 2 Oct 2013

Genetic discovery could take guesswork out of prescribing correct dose of drugs

The discovery of genetic differences affecting up to a third of the population could take the guesswork out of prescribing the correct dose of 25 percent of drugs currently on the market, researchers say.

2 Oct 2013

No significant association between advent of depression and subsequent advent of cancer

All of the absences from work for depression, certified by doctors, were recorded as well as many questionnaires measuring depressive moods. The results, which will be published in The American Journal of Epidemiology, do not indicate any significant association between a person experiencing the symptoms of depression during their lifetime and their subsequently contracting cancer.

2 Oct 2013

Nia exercise benefits individuals with breast cancer

Researchers from ProMedica Cancer Institute have released new findings about the benefits of Nia exercise for individuals with breast cancer. Nia is a sensory-based movement practice that heals the body using music and movement.

2 Oct 2013

Opinions on shutdown: Using Obamacare is a sham cause; GOP isn't crazy; what's the endgame?

House Republicans' irresponsible brinkmanship may finally lead to the government shutdown that some of its members have been coveting since they took control of that chamber in 2011. This time, though, the fight hasn't been a battle over spending on federal agencies. It's been a symbolic one over the 2010 Patient Protection and Affordable Care Act, a.k.a. Obamacare. And it's been a sham. The inconvenient truth for the GOP is that "defunding Obamacare," as the House tried to do, wouldn't stop most of the major provisions of the health care law, some of which have already gone into effect

2 Oct 2013

NIH awards 10 new grants to support genomics research in Africa

The National Institutes of Health has awarded 10 new grants totaling up to $17 million over the next four years to support genomics research in Africa, as part of the Human Heredity and Health in Africa (H3Africa) program

2 Oct 2013

Obamacare winners and losers

NPR looks at what the federal government can learn from Massachusetts as health insurance exchanges roll out. Other media outlets check in with insurers, Wall Street traders, health care stakeholders and those who had previously been denied coverage in the individual insurance market.

2 Oct 2013

FDA grants accelerated approval of Perjeta for people with HER2-positive early stage breast cancer

The U.S. Food and Drug Administration granted accelerated approval of a Perjeta- (pertuzumab) regimen for neoadjuvant treatment (use before surgery) in people with high-risk, HER2-positive early stage breast cancer.

2 Oct 2013

Cancer News and Research

Latest Cancer News and Research

Research: Children with inherited anti-inflammatory defect may have predisposition to lymphoma

Depressed people may have triple times risk of developing Parkinson's

NCI explores how erectile dysfunction drugs work to prevent colon cancer

UCLA study shows how cocaine makes immune cells susceptible to HIV

New agreement to expand scope of research project to evaluate MCT-485 for primary liver cancer

Saint Luke's liver transplantation program receives CMS certification

Data analyses from Brisdelle Phase 3 pivotal trials to be showcased at NAMS' meeting

Epigenetic Markers Found For Head And Neck Cancers

Hypertension Drug May Aid Cancer Treatment

Sun Pharma, Intrexon Team Up To Target Ocular Diseases

Esteya system for high precision skin cancer treatment gets FDA clearance

Laboratory testing kit that estimates risk of breast cancer relapse gets FDA approval

Sheffield Hallam University encourage careers in radiotherapy with a series of open events

Genetic discovery could take guesswork out of prescribing correct dose of drugs

No significant association between advent of depression and subsequent advent of cancer

Nia exercise benefits individuals with breast cancer

Opinions on shutdown: Using Obamacare is a sham cause; GOP isn't crazy; what's the endgame?

NIH awards 10 new grants to support genomics research in Africa

Obamacare winners and losers

FDA grants accelerated approval of Perjeta for people with HER2-positive early stage breast cancer

Understanding the DNA Damage Response in Innate Immunity eBook

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Obesity, GLP-1s, and metabolic care

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Obesity, GLP-1s, and metabolic care

Newsletters you may be interested in